|
1
|
Božinović K, Sabol I, Dediol E, Milutin
Gašperov N, Manojlović S, Vojtechova Z, Tachezy R and Grce M:
Genome-wide miRNA profiling reinforces the importance of miR-9 in
human papillomavirus associated oral and oropharyngeal head and
neck cancer. Sci Rep. 9:23062019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cohan DM, Popat S, Kaplan SE, Rigual N,
Loree T and Hicks WL Jr: Oropharyngeal cancer: Current
understanding and management. Curr Opin Otolaryngol Head Neck Surg.
17:88–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Preuss SF, Quante G, Semrau R, Mueller RP,
Klussmann JP and Guntinas-Lichius O: An analysis of surgical
complications, morbidity, and cost calculation in patients
undergoing multimodal treatment for operable oropharyngeal
carcinoma. Laryngoscope. 117:101–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Biktasova A, Hajek M, Sewell A, Gary C,
Bellinger G, Deshpande HA, Bhatia A, Burtness B, Judson B, Mehra S,
et al: Demethylation therapy as a targeted treatment for human
papillomavirus-associated head and neck cancer. Clin Cancer Res.
23:7276–7287. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cancer Genome Atlas Network, .
Comprehensive genomic characterization of head and neck squamous
cell carcinomas. Nature. 517:576–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beck B and Blanpain C: Unravelling cancer
stem cell potential. Nat Rev Cancer. 13:727–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie X, Teknos TN and Pan Q: Are all cancer
stem cells created equal? Stem Cells Transl Med. 3:1111–1115. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identificationof human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ricci-Vitiani L, Pagliuca A, Palio E,
Zeuner A and De Maria R: Colon cancer stem cells. Gut. 57:538–548.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and Mullerian
Inhibiting Substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Albers AE, Chen C, Köberle B, Qian X,
Klussmann JP, Wollenberg B and Kaufmann AM: Stem cells in squamous
head and neck cancer. Crit Rev Oncol Hematol. 81:224–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morrison R, Schleicher SM, Sun Y, Niermann
KJ, Kim S, Spratt DE, Chung CH and Lu B: Targeting the mechanisms
of resistance to chemotherapy and radiotherapy with the cancer stem
cell hypothesis. J Oncol. 12011:9418762011.
|
|
16
|
Klonisch T, Wiechec E, Hombach-Klonisch S,
Ande SR, Wesselborg S, Schulze-Osthoff K and Los M: Cancer stem
cell markers in common cancers-therapeutic implications. Trends Mol
Med. 14:450–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dingli D and Michor F: Successful therapy
must eradicate cancer stem cells. Stem Cells. 24:2603–2610. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Laban S, Steinmeister L, Gleißner L, Grob
TJ, Grénman R, Petersen C, Gal A, Knecht R, Dikomey E and Kriegs M:
Sorafenib sensitizes head and neck squamous cell carcinoma cells to
ionizing radiation. Radiother Oncol. 109:286–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maushagen R, Reers S, Pfannerstill AC,
Hahlbrock A, Stauber R, Rahmanzadeh R, Rades D, Pries R and
Wollenberg B: Effects of paclitaxel on permanent head and neck
squamous cell carcinoma cell lines and identification of
anti-apoptotic caspase 9b. J Cancer Res Clin Oncol. 142:1261–1271.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tamagawa S, Beder LB, Hotomi M, Gunduz M,
Yata K, Grenman R and Yamanaka N: Role of miR-200c/miR-141 in the
regulation of epithelial-mesenchymal transition and migration in
head and neck squamous cell carcinoma. Int J Mol Med. 33:879–886.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJS and chmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McDermott SC, Rodriguez-Ramirez C,
McDermott SP, Wicha MS and Nör JE: FGFR signaling regulates
resistance of head and neck cancer stem cells to cisplatin.
Oncotarget. 9:25148–25165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Phi LTH, Sari IN, Yang YG, Lee SH, Jun N,
Kim KS, Lee YK and Kwon HY: Cancer stem cells (CSCs) in drug
resistance and their therapeutic implications in cancer treatment.
Stem Cells Int. 2018:54169232018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prieto-Vila M, Takahashi RU, Usuba W,
Kohama I and Ochiya T: Drug resistance driven by cancer stem cells
and their niche. Int J Mol Sci. 18(pii): E25742017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ghisolfi L, Keates AC, Hu X, Lee DK and Li
CJ: Ionizing radiation induces stemness in cancer cells. PLoS One.
7:e436282012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gomez-Casal R, Bhattacharya C, Ganesh N,
Bailey L, Basse P, Gibson M, Epperly M and Levina V: Non-small cell
lung cancer cells survived ionizing radiation treatment display
cancer stem cell and epithelial-mesenchymal transition phenotypes.
Mol Cancer. 12:942013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee Y, Kim KH, Kim DG, Cho HJ, Kim Y,
Rheey J, Shin K, Seo YJ, Choi YS, Lee JI, Lee J, Joo KM and Nam DH:
FoxM1 promotes stemness and radio-resistance of glioblastoma by
regulating the master stem cell regulator sox2. PLoS One.
10:e01377032015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barr MP, Gray SG, Hoffmann AC, Hilger RA,
Thomale J, O'Flaherty JD, Fennell DA, Richard D, O'Leary JJ and
O'Byrne KJ: Generation and characterization of cisplatin-resistant
non-small cell lung cancer cell lines displaying a stem-like
signature. PLoS One. 8:e541932013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ghosh RD, Ghuwalewala S, Das P, Mandloi S,
Alam SK, Chakraborty J, Sarkar S, Chakrabarti S, Panda CK and
Roychoudhury S: MicroRNA profiling of cisplatin-resistant oral
squamous cell carcinoma cell lines enriched with
cancer-stem-cell-like and epithelial-mesenchymal transition-type
features. Sci Rep. 6:239322016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miyazaki H, Takahashi RU, Prieto-Vila M,
Kawamura Y, Kondo S, Shirota T and Ochiya T: CD44 exerts a
functional role during EMT induction in cisplatin-resistant head
and neck cancer cells. Oncotarget. 9:10029–10041. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang P, Xu C, Zhou M, Zhou H, Dong W, Wu
X, Chen A and Feng Q: RXRα-enriched cancer stem cell-like
properties triggered by CDDP in head and neck squamous cell
carcinoma (HNSCC). Carcinogenesis. 39:252–262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang AL, Owen JH, Hauff SJ, Park JJ,
Papagerakis S, Bradford CR, Carey TE and Prince ME: Head and neck
cancer stem cells: The effect of HPV-an in vitro and mouse study.
Otolaryngol Head Neck Surg. 149:252–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reid P, Wilson P, Li Y, Marcu LG,
Staudacher AH, Brown MP and Bezak E: In vitro investigation of head
and neck cancer stem cell proportions and their changes following
X-ray irradiation as a function of HPV status. PLoS One.
12:e01861862017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang M, Kumar B, Piao L, Xie X, Schmitt
A, Arradaza N, Cippola M, Old M, Agrawal A, Ozer E, et al: Elevated
intrinsic cancer stem cell population in human
papillomavirus-associated head and neck squamous cell carcinoma.
Cancer. 120:992–1001. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vlashi E, Chen AM, Boyrie S, Yu G, Nguyen
A, Brower PA, Hess CB and Pajonk F: Radiation-induced
dedifferentiation of head and neck cancer cells into cancer stem
cells depends on human papillomavirus status. Int J Radiat Oncol
Biol Phys. 94:1198–1206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chaffer CL, Brueckmann I, Scheel C,
Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y,
Polyak K, et al: Normal and neoplastic nonstem cells can
spontaneously convert to a stem-like state. Proc Natl Acad Sci USA.
108:7950–7955. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Biddle A, Liang X, Gammon L, Fazil B,
Harper LJ, Emich H, Costea DE and Mackenzie IC: Cancer stem cells
in squamous cell carcinoma switch between two distinct phenotypes
that are preferentially migratory or proliferative. Cancer Res.
71:5317–5326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Almeida LO, Guimarães DM, Squarize CH and
Castilho RM: Profiling the behavior of distinct populations of head
and neck cancer stem cells. Cancers (Basel). 8(pii): E72016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen YC, Chen YW, Hsu HS, Tseng LM, Huang
PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde
dehydrogenase 1 is a putative marker for cancer stem cells in head
and neck squamous cancer. Biochem Biophy Res Commun. 385:307–313.
2009. View Article : Google Scholar
|
|
41
|
Sayed SI, Dwivedi RC, Katna R, Garg A,
Pathak KA, Nutting CM, Rhys-Evans P, Harrington KJ and Kazi R:
Implications of understanding cancer stem cell (CSC) biology in
head and neck squamous cell cancer. Oral Oncol. 47:237–243. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Marcato P, Dean CA, Giacomantonio CA and
Lee PW: Aldehyde dehydrogenase: Its role as a cancer stem cell
marker comes down to the specific isoform. Cell Cycle.
10:1378–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qian X, Wagner S, Ma C, Coordes A, Gekeler
J, Klussmann JP, Hummel M, Kaufmann AM and Albers AE: Prognostic
significance of ALDH1A1-positive cancer stem cells in patients with
locally advanced, metastasized head and neck squamous cell
carcinoma. J Cancer Res Clin Oncol. 140:1151–1158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Curtarelli RB, Gonçalves JM, Dos Santos
LGP, Savi MG, Nör JE, Mezzomo LAM and Rodríguez Cordeiro MM:
Expression of cancer stem cell biomarkers in human head and neck
carcinomas: A systematic review. Stem Cell Rev. 14:769–784. 2018.
View Article : Google Scholar
|
|
45
|
Zhou C and Sun B: The prognostic role of
the cancer stem cell marker aldehyde dehydrogenase 1 in head and
neck squamous cell carcinomas: A meta-analysis. Oral Oncol.
50:1144–1148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yata K, Beder LB, Tamagawa S, Hotomi M,
Hirohashi Y, Grenman R and Yamanaka N: MicroRNA expression profiles
of cancer stem cells in head and neck squamous cell carcinoma. Int
J Oncol. 47:1249–1256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Macha MA, Rachagani S, Qazi AK, Jahan R,
Gupta S, Patel A, Seshacharyulu P, Lin C, Li S, Wang S, et al:
Afatinib radiosensitizes head and neck squamous cell carcinoma
cells by targeting cancer stem cells. Oncotarget. 8:20961–20973.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Setúbal Destro Rodrigues MF, Gammon L,
Rahman MM, Biddle A, Nunes FD and Mackenzie IC: Effects of
cetuximab and erlotinib on the behaviour of cancer stem cells in
head and neck squamous cell carcinoma. Oncotarget. 9:13488–13500.
2018.PubMed/NCBI
|
|
49
|
Subramanian C, Kovatch KJ, Sim MW, Wang G,
Prince ME, Carey TE, Davis R, Blagg BSJ and Cohen MS: Novel
c-terminal Heat shock protein 90 inhibitors (KU711 and Ku757) are
effective in targeting head and neck squamous cell carcinoma cancer
stem cells. Neoplasia. 19:1003–1011. 2017. View Article : Google Scholar : PubMed/NCBI
|
